After 400% Surge, Should Investors Care About Monte Rosa Insider Sale?
A biotech stock sprinted 400% in a year, and an insider sale worth about $882k followed. The question for investors: ...
Passive strategies for retirement prioritize low costs and broad market exposure, delivering reliable long-term growth without constant tweaking.
23,939 articlesA biotech stock sprinted 400% in a year, and an insider sale worth about $882k followed. The question for investors: ...
With AMD’s rally making headlines, a slate of overlooked names could ride the AI and defense cycle higher. Here are f...
Vanguard’s International High Dividend Yield ETF has raised payouts in 2025 and 2026, but the durability of its forei...
Cadence Design Systems posted a strong Q1 FY2026, underscoring a rising demand for AI chip design tools. A record bac...
Vitalik Buterin unveils a two step plan to shrink Ethereum state and move verification to validators via zero knowled...
A leading mega-cap health stock dropped last year but started the year with a powerful rebound. This guide breaks dow...
SBI Holdings has led a $125 million Series C round for Tarun Chitra’s Gauntlet, the DeFi risk analytics platform. The...
XRP sits in a tight range around $1.10 as traders await regulatory developments. A clean break above $1.20 could redr...
Mega-cap AI bets are fueling a surge in debt issuance this year, prompting fresh debate over whether the AI expansion...
Massachusetts officials host a ceremonial welcome for an orange traffic cone inspired by Scottish World Cup fans, exa...
Base founder Jesse Pollak is stepping back from day-to-day leadership after acknowledging a failed social strategy. T...
Chevron is expanding its footprint beyond traditional oil and gas as it eyes large-scale power deals. A landmark 2.7 ...